Edwards Lifesciences (EW) VP Donald Bobo logs tax share disposal and holdings

Rhea-AI Filing Summary

Edwards Lifesciences Corp executive Donald E. Bobo Jr., Corporate Vice President of Strategy and Corporate Development, reported routine share updates and a small tax-related disposition of company stock. The filing shows a tax-withholding disposition of 469 shares of common stock at $83.98 per share, leaving him with 20,797.2532 shares held directly.

The filing also reports indirect holdings of 121,756 common shares held by a trust and 38,969.5756 shares represented in a 401(k) plan account, based on the plan administrator’s most recent statement. Overall, this Form 4 reflects mainly administrative updates and tax withholding rather than open-market buying or selling.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider BOBO DONALD E JR

Role CVP,Strategy/Corp Development

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	469	$83.98	$39K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 20,797.253 shares (Direct, null); Common Stock — 38,969.576 shares (Indirect, 401(k))

Footnotes (1)

1. [object Object]

Key Figures

Tax-withholding shares: 469 shares Tax-withholding price: $83.98/share Direct holdings after transaction: 20,797.2532 shares +2 more

5 metrics

Tax-withholding shares 469 shares Disposition under code F at $83.98 per share

Tax-withholding price $83.98/share Price for 469-share tax-withholding disposition

Direct holdings after transaction 20,797.2532 shares Common stock held directly after tax withholding

Trust holdings 121,756 shares Common stock held indirectly by trust

401(k) plan shares 38,969.5756 shares Common stock represented in 401(k) plan statement

Key Terms

tax-withholding disposition, Common Stock, 401(k) Plan, indirect ownership

4 terms

tax-withholding disposition financial

"The filing shows a tax-withholding disposition of 469 shares of common stock"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Common Stock financial

"tax-withholding disposition of 469 shares of common stock at $83.98 per share"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

401(k) Plan financial

"shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator"

A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

indirect ownership financial

"reports indirect holdings of 121,756 common shares held by a trust"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOBO DONALD E JR

(Last) (First) (Middle)

ONE EDWARDS WAY

(Street)

IRVINE CALIFORNIA 92614

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Edwards Lifesciences Corp [ EW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CVP,Strategy/Corp Development

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/03/2026		F		469	D	$83.98	20,797.2532	D
Common Stock								38,969.5756(1)	I	401(k)
Common Stock								121,756	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

	Linda J. Park, Attorney-in-Fact	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Edwards Lifesciences (EW) executive Donald E. Bobo Jr. report on this Form 4?

Donald E. Bobo Jr. reported a small tax-related disposition of Edwards Lifesciences common stock and updated his direct and indirect share holdings. The filing documents share counts held directly, by a trust, and in a 401(k) plan.

How many Edwards Lifesciences (EW) shares were disposed of for taxes in this filing?

The filing shows a tax-withholding disposition of 469 shares of Edwards Lifesciences common stock at $83.98 per share. This reflects shares delivered to cover tax obligations, not an open-market sale, under transaction code F.

What are Donald E. Bobo Jr.’s direct Edwards Lifesciences (EW) holdings after this Form 4?

After the reported tax-withholding disposition, Donald E. Bobo Jr. holds 20,797.2532 Edwards Lifesciences common shares directly. This figure represents his remaining direct ownership position as reported in the Form 4 filing.

What indirect Edwards Lifesciences (EW) holdings are reported for Donald E. Bobo Jr.?

The Form 4 reports 121,756 Edwards Lifesciences common shares held indirectly by a trust and 38,969.5756 shares represented in a 401(k) plan account, based on the plan administrator’s most recent statement.

Does this Edwards Lifesciences (EW) Form 4 show any open-market stock sales or purchases?

The Form 4 does not show open-market purchases or sales. It records a tax-withholding disposition of 469 shares under code F and two holding entries updating indirect share positions in a trust and a 401(k) plan.